📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s42003-024-05924-0

PubMed Identifier: 38448753

Publication URI: http://europepmc.org/abstract/MED/38448753

Type: Journal Article/Review

Volume: 7

Parent Publication: Communications biology

Issue: 1

ISSN: 2399-3642